Translation of "are not expected to decrease" to Slovene language:

Dictionary English-Slovene

Decrease - translation :

Expected - translation :

Keywords : Zmanjšajo Upad Zmanjšati Znižanje Zmanjša Pričakoval Pričakovala Pričakovali Pričakoval Pričakovano

Examples (External sources, not reviewed)

Rifampicin and rifapentine are expected to decrease plasma concentrations of etravirine.	Pričakovati je, da rifampicin in rifapentin zmanjšata plazemsko koncentracijo etravirina.
Carbazamepine, phenobarbital and phenytoin are expected to decrease plasma concentrations of etravirine.	Pričakovati je, da karbamazepin, fenobarbital in fenitoin zmanjšajo plazemske koncentracije etravirina.
Dexamethasone is expected to decrease plasma concentrations of etravirine	Pričakovati je, da pri sočasni uporabi deksametazon zmanjša plazemsko koncentracijo etravirina.
The swelling is expected to decrease within two days.	Oteklina naj bi izginila v dveh dneh.
INTELENCE is expected to decrease plasma concentrations of these antiarrhythmics.	Pričakovati je, da zdravilo INTELENCE zmanjša plazemske koncentracije teh antiaritmikov.
However, any effects are not to be expected.	Tovrstnih učinkov tudi ni pričakovati.
Undesirable effects typical of opioids are to be expected with Rapinyl they tend to decrease in intensity with continued use.	Pri Rapinylu je pričakovati neželene učinke ki so značilni za opioide njihova intenzivnost ob uporabi s časom navadno pada.
Etravirine is expected to decrease plasma concentrations of cyclosporine, sirolimus or tacrolimus.	Pričakovati je, da etravirin zmanjša plazemske koncentracije ciklosporina, sirolimusa ali takrolimusa.
As weight increases from 65 to 200 kg, Cmax is expected to decrease 24 and Ctrough is expected to increase by 5 .	Ko se telesna masa poveča s 65 na 200 kg, je pričakovano zmanjšanje Cmax 24 in pričakovano povečanje Cdno za 5 .
St John s wort is expected to decrease the plasma concentrations of etravirine.	Pričakovati je, da bi sočasna uporaba povzročila zmanjšanje plazemskih koncentracij etravirina.
Genotoxic and carcinogenic potential are not expected.	Ne pričakujemo, da bi zdravilo lahko imelo genotoksičen ali karcinogen potencial.
Genotoxic and carcinogenic potential are not expected.	Genotoksičnosti in kancerogenosti ni pričakovati.
Genotoxic and carcinogenic potential are not expected.	Genotoksični in karcinogeni potencial zdravila ni pričakovan.
As weight increases from 65 to 200 kg, Cmax is expected to decrease 24 on	Ko se telesna masa poveča s 65 na 200 kg, je pričakovano zmanjšanje Cmax 24 in pričakovano povečanje Cdno za 5 .
Interaction with indinavir ritonavir not studied Ritonavir induces glucuronidation and as a result is expected to decrease the plasma concentrations of atovaquone.	Ritonavir inducira glukuronidacijo, zato se pričakuje zmanjšana koncentracija atovakona v plazmi.
Concurrent administration of bupropion with repeated doses of ritonavir is expected to decrease bupropion levels.	Pričakovati je, da sočasna uporaba bupropiona s ponavljajočimi odmerki ritonavirja zmanjša raven bupropiona.
Drugs that are substrates for these P450 enzymes are not expected to interact with TRISENOX.	Za zdravila, ki so substrati encimov P450, se ne pričakuje, da bodo medsebojno delovala z zdravilom TRISENOX.
Although not studied, carbamazepine or phenobarbital are likely to significantly decrease plasma voriconazole concentrations.	Čeprav to ni raziskano, je verjetno, da karbamazepin ali fenobarbital pomembno zmanjšata koncentracijo vorikonazola v plazmi.
Hence, interactions due to inhibition or induction of CYP450 isoenzymes are not expected.	Zato ni pričakovati interakcij zaradi zaviranja ali indukcije izoencimov CYP450.
A slight decrease in renal excretion of gabapentin that is observed when it is coadministered with cimetidine is not expected to be of clinical importance.	Med sočasno uporabo gabapentina in cimetidina se ledvično izločanje gabapentina rahlo zmanjša, vendar ni pričakovati, da bi bilo to klinično pomembno.
Interferences with determination of blood glucose levels are not expected.	Motenj pri določanju ravni krvne glukoze naj ne bi bilo.
Therefore, related medicinal product interactions are not expected with dabigatran.	Zato tovrstnih interakcij z drugimi zdravili pri dabigatranu ne pričakujemo.
Since the renal clearance of imatinib is negligible, a decrease in free imatinib clearance is not expected in patients with renal insufficiency.	Ker je ledvični očistek imatiniba zanemarljiv, pri bolnikih z ledvično insuficienco ni pričakovati zmanjšanja očistka prostega imatiniba.
Interaction with indinavir ritonavir not studied Ritonavir induces oxidation by CYP2C9 and glucuronidation and as a result is expected to decrease the plasma concentrations of anticonvulsants.	Ritonavir inducira oksidacijo, ki jo povzroča CYP2C9, in glukuronidacijo, zato se pričakuje zmanjšanje koncentracij antikonvulzivov v plazmi.
Interaction with indinavir ritonavir not studied Ritonavir induces oxidation by CYP2C9 and glucuronidation and as a result is expected to decrease the plasma concentrations of anticonvulsants.	Ritonavir inducira oksidacijo, ki jo povzroča CYP2C9, in glukuronidacijo, zato se pričakuje
with stavudine is not expected to	(0, 10 0, 27)
with stavudine is not expected to	pomembnejših sprememb v
APTIVUS, co administered with low dose ritonavir, is expected to decrease meperidine concentrations and increase normeperidine metabolite concentrations.	Zdravilo APTIVUS ob hkratnih majhnih odmerkih ritonavirja predvidoma zmanjša koncentracijo meperidina in poveča koncentracijo presnovka normeperidina.
A significant decrease in the burden for companies exempted from reporting to Intrastat through this Regulation is expected.	Pričakuje se bistveno zmanjšanje bremena za družbe, ki so po tej uredbi oproščene poročanja Intrastatu.
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of rivaroxaban.	Protaminijev sulfat in vitamin K ne vplivata na antikoagulacijski učinek rivaroksabana.
Pharmacokinetic drug interactions involving CYP450 are not expected (see section 5.2)	Farmakokinetične interakcije, povezane s CYP450, niso pričakovane (glejte poglavje 5. 2).
50 dependent on CYP3A4, and interactions are not expected with Kaletra.	Presnova pravastatina in fluvastatina ni odvisna od CYP3A4 in medsebojnega delovanja z zdravilom Kaletra ni pričakovati.
He blesseth them also, so that they are multiplied greatly and suffereth not their cattle to decrease.	Blagoslavlja jih tako, da se množijo silno, in njih živine ne zmanjšuje.
However, since the renal clearance of tipranavir is negligible, a decrease in total body clearance is not expected in patients with renal impairment.	Ker je njegov ledvični očistek neznaten, pri bolnikih z ledvično okvaro ne pričakujemo zmanjšanja skupnega očistka iz telesa.
The renal clearance of ritonavir is negligible therefore, a decrease in the total body clearance is not expected in patients with renal impairment.	Ledvični očistek ritonavirja je zanemarljiv zato pri bolnikih z okvaro ledvic ni pričakovati zmanjšanja celotnega telesnega očistka.

Prikažite to stran v Slovenu